FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Asthma Drug Spending 4 Times Higher in 10 Years

[ Price : $8.95]

The Agency on Healthcare Research and Quality says that spending on Rx asthma drugs has quadrupled in 10 years.

Noven Sues Watson for Daytrana Patent Infringement

[ Price : $8.95]

Noven Pharmaceutical files a lawsuit against Watson Pharmaceuticals for infringement of a patent for ADHD patch Daytrana.

FDA Clears Candelis Software Suite

[ Price : $8.95]

FDA clears a Candelis 510(k) for its ASTRA cloud-hosted software suite for medical image transmission.

Reviewers Question Azilect Efficacy for New Indication

[ Price : $8.95]

FDA medical reviewers tell the Peripheral and Central Nervous System Drugs Advisory Committee they have questions about Azilects e...

WHO Calls for a Switch Away from Dental Amalgam

[ Price : $8.95]

In a new 61-page report, the World Health Organization calls for a switch away from use of dental amalgam because it is a signific...

NIH Head Sees Big Promise for Orphan Drugs in DNA Cost Drop

[ Price : $8.95]

NIH director Francis Collins explains that a dramatic reduction in cost for DNA sequencing holds profound promise for developing n...

FDA Severely Damages Device Industry Creativity: Lawyer

[ Price : $8.95]

In a Competitive Enterprise Institute issue analysis, noted medical device lawyer Larry Pilot criticizes what he describes as poor...

Bayer, Onyx Revise Agreement on Cancer Drugs

[ Price : $8.95]

Bayer Healthcare and Onyx Pharmaceuticals enter into a new agreement related to regorafenib, a late-stage oncology compound, and N...

Zilver Stent Safe, Effective: Reviewers

[ Price : $8.95]

FDA asks the Circulatory Systems Devices Advisory Panel members whether they believe the Cook Zilver peripheral artery coated sten...

FDA Grant Seeks to Advance Pediatric Devices

[ Price : $8.95]

FDA awards Georgia Tech, Childrens Healthcare of Atlanta, Emory University and Saint Josephs Translational Research Institute (SJT...